Press Resease

Contrast Injector Market - Global Industry Analysis

Contrast Injector Market By Product (Injector Systems, Consumables, and Accessories) and By Application (Radiology, Interventional Cardiology, Interventional Radiology): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 05-May-2021 Category: Medical Device Report Format : PDF Pages: 130 Report Code: ZMR-2086 Status : Published

The global contrast injector market accounted for USD 765 Million in 2020 and is expected to reach USD 1,447 Million by 2028, growing at a CAGR of 8.2% from 2021 to 2028.

Description

Market Overview

The global contrast injector market accounted for USD 765 Million in 2020 and is expected to reach USD 1,447 Million by 2028, growing at a CAGR of 8.2% from 2021 to 2028.

Contrast dye or agent is a chemical substance that is used for increasing contrast of fluids in the human body during medical imaging. Contrast agents are used for improving radiodensity during a medical imaging scan of a tissue or an organ. There are various types of contrast agents used for improving visibility of gastrointestinal tract and vessels. In X-rays, most commonly used contrast agents are iodine and barium and during magnetic resonance imaging scans gadolinium is utilized as an MRI contrast agent.

Contrast injector are used for injecting contrast agent in human body during a radiography scan.  These contrast injectors help in monitoring contrast dosage, recording quantity of contract agent used, detecting potential health hazards during scan, and increasing dosage speed during tests. Contrast injectors play a crucial role in ensuring patient safety and imaging quality.

COVID-19 Impact Analysis

The global contrast injector market growth has witnessed a decrease during COVID-19 crisis as there has been decrease in the number of new imaging labs opened in around the world owing to trade restrictions and lockdown enforcement imposed by governments. Many hospitals and diagnostic centers have limited scanning as there is risk for COVID virus transmission. Trade restrictions among countries and continents have also affected production and have resulted in supply chain disruption in medical industry. This factor is likely to hamper the contrast injector market growth. However, there has been significant increase in the number of CT scans done during COVID-19 pandemic as CT scans can be useful in diagnosing COVID-19 infection among critically ill patients for suspicion of infection. This rise in the number of CT tests done is anticipated to trigger market growth.

Growth Factors

Growing healthcare industry around the world has accelerated the number of diagnosis done for detecting various disorders in humans. This rise in the number of tests has also been bolstered by increasing number of individuals suffering from cancer, brain disorders, spinal diseases, and physical injuries. Such growth in the number of  tests done is likely to boost the demand for contrast agents in medical diagnostic industry, which may also fuel the demand for contrast injectors.

There has been significant increase in investment from municipal and federal authorities in developing and expanding healthcare infrastructure in urban as well as rural areas of the world. This increase in investment in healthcare industry is expected to increase the number of new diagnostic centers in developing as well as developed parts of the world. This anticipated rise in the number of diagnostic centers should boost the demand for new contrast injectors. Further, there has also been growth in the number of imaging centers for treating various chronic disorders which should also contribute to the growth of the contrast injectors market globally.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Product Segment Analysis Preview

In terms of products, the consumables segment dominated the global contrast injectors market in 2020. Consumables such as injector heads, syringes, and tubes hold an important position in imaging test as these ensure efficient contrast dosage and scan quality. Also, there has been significant growth in the demand for high quality consumables to ensure effective imaging scan results. This trend may also accelerate the market growth.

Injector systems segment is estimated to grow at a highest growth rate owing to growing number of diagnostic centers worldwide. Contrast injectors systems are used in imaging scans like CT, MRI, and angiography. In recent years there has been a significant rise in the number of individuals suffering from cardiovascular disorders, which has propelled the angiography scan demand worldwide. Such a ride should contribute the demand for contrast injector consumables.  

Application Segment Analysis Preview

Based on applications, the radiology segment dominated the global market, accounting for a market share of approximately 50% in 2020. Various types of imaging technologies such as computed tomography (CT), positron emission tomography (PET), and magnetic resonance imaging (MRI) are used by radiologists for diagnosing different types of chronic diseases such as blood clots, thrombosis, cancer, and tumor. These technologies use contrast injectors for effective scans and avoiding health hazards to patients. Such use of contrast injectors should proliferate the contrast injectors market growth for radiology applications.

Regional Analysis Preview

Asia Pacific is expected to grow at the fastest rate in years ahead pertaining to soaring growth in the healthcare and medical sector in the region. Changing lifestyle and eating patterns have accelerated the prevalence of various chronic diseases such as diabetes, heart disorders, and cancers. Such rise in the number of individuals suffering from chronic diseases has fueled the imaging scan market in Asia Pacific, which has led to an increase in the number of new diagnostic centers in the region. This is likely to proliferate the Asia Pacific contrast injectors market.

North American region held a major share in the global contrast injectors market, constituting a market share of around 35% in 2020. Existing developed and established healthcare system in countries like United States and Canada has boosted adoption of advanced imaging technologies. Such adoption of advanced technologies should contribute to the growth of the contrast injector market growth.

Key Market Players & Competitive Landscape

Some of key players in contrast injector market are Bayer HealthCare, GE Healthcare, Bracco Imaging S.p.A., AngioDynamics, Medtron AG, ulrich GmbH & Co. KG, Guerbet Group, VIVID IMAGING , Sino Medical Device Technology Co., Ltd., Apollo RT Co., Ltd., and Nemoto Kyorindo Co., Ltd.

The global Contrast Injector market is segmented as follows:

By Product

  • Injector Systems,
  • Consumables
  • Accessories

By Application

  • Radiology
  • Interventional Cardiology
  • Interventional Radiology

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Product
        • 2.1.1.2. Market Attractiveness Analysis, By Application
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Contrast Injector Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Contrast Injector Market – Product Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
    • 4.2. Injector Systems
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Consumables
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Accessories
      • 4.4.1. Market Size and Forecast, By Region (USD Million)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Contrast Injector Market – Application Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 5.2. Radiulogy
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Interventional Cardiulogy
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Interventional Radiulogy
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Contrast Injector Market – Regional Analysis
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.2.2. North America Market Revenue, By Product, 2016 – 2028
      • 6.2.3. North America Market Revenue, By Application, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.4.1. U.S. Market Revenue, By Product, 2016 – 2028
        • 6.2.4.2. U.S. Market Revenue, By Application, 2016 – 2028
      • 6.2.5. Canada
        • 6.2.5.1. Canada Market Revenue, By Product, 2016 – 2028
        • 6.2.5.2. Canada Market Revenue, By Application, 2016 – 2028
      • 6.2.6. Mexico
        • 6.2.6.1. Mexico Market Revenue, By Product, 2016 – 2028
        • 6.2.6.2. Mexico Market Revenue, By Application, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.3.2. Europe Market Revenue, By Product, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By Application, 2016 – 2028
      • 6.3.4. Germany
        • 6.3.4.1. Germany Market Revenue, By Product, 2016 – 2028
        • 6.3.4.2. Germany Market Revenue, By Application, 2016 – 2028
      • 6.3.5. France
        • 6.3.5.1. France Market Revenue, By Product, 2016 – 2028
        • 6.3.5.2. France Market Revenue, By Application, 2016 – 2028
      • 6.3.6. U.K.
        • 6.3.6.1. U.K. Market Revenue, By Product, 2016 – 2028
        • 6.3.6.2. U.K. Market Revenue, By Application, 2016 – 2028
      • 6.3.7. Italy
        • 6.3.7.1. Italy Market Revenue, By Product, 2016 – 2028
        • 6.3.7.2. Italy Market Revenue, By Application, 2016 – 2028
      • 6.3.8. Spain
        • 6.3.8.1. Spain Market Revenue, By Product, 2016 – 2028
        • 6.3.8.2. Spain Market Revenue, By Application, 2016 – 2028
      • 6.3.9. Rest of Europe
        • 6.3.9.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
        • 6.3.9.2. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 6.4.4. China
        • 6.4.4.1. China Market Revenue, By Product, 2016 – 2028
        • 6.4.4.2. China Market Revenue, By Application, 2016 – 2028
      • 6.4.5. Japan
        • 6.4.5.1. Japan Market Revenue, By Product, 2016 – 2028
        • 6.4.5.2. Japan Market Revenue, By Application, 2016 – 2028
      • 6.4.6. India
        • 6.4.6.1. India Market Revenue, By Product, 2016 – 2028
        • 6.4.6.2. India Market Revenue, By Application, 2016 – 2028
      • 6.4.7. South Korea
        • 6.4.7.1. South Korea Market Revenue, By Product, 2016 – 2028
        • 6.4.7.2. South Korea Market Revenue, By Application, 2016 – 2028
      • 6.4.8. South-East Asia
        • 6.4.8.1. South-East Asia Market Revenue, By Product, 2016 – 2028
        • 6.4.8.2. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 6.4.9. Rest of Asia Pacific
        • 6.4.9.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
        • 6.4.9.2. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.5.2. Latin America Market Revenue, By Product, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By Application, 2016 – 2028
      • 6.5.4. Brazil
        • 6.5.4.1. Brazil Market Revenue, By Product, 2016 – 2028
        • 6.5.4.2. Brazil Market Revenue, By Application, 2016 – 2028
      • 6.5.5. Argentina
        • 6.5.5.1. Argentina Market Revenue, By Product, 2016 – 2028
        • 6.5.5.2. Argentina Market Revenue, By Application, 2016 – 2028
      • 6.5.6. Rest of Latin America
        • 6.5.6.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
        • 6.5.6.2. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.4. GCC Countries
        • 6.6.4.1. GCC Countries Market Revenue, By Product, 2016 – 2028
        • 6.6.4.2. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 6.6.5. South Africa
        • 6.6.5.1. South Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.5.2. South Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.6. Rest of Middle-East Africa
        • 6.6.6.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.6.2. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 7 Contrast Injector Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technology Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8 Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Contrast Injector Market: Company Market Share, 2019
      • 8.1.2. Global Contrast Injector Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 8.1.3. Global Contrast Injector Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Contrast Injector Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9 Company Profiles
    • 9.1. Bayer HealthCare
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. GE Healthcare
    • 9.3. Bracco Imaging S.p.A.
    • 9.4. AngioDynamics
    • 9.5. Medtron AG
    • 9.6. ulrich GmbH & Co. KG
    • 9.7. Guerbet Group
    • 9.8. VIVID IMAGING
    • 9.9. Sino Medical Device Technology Co., Ltd.
    • 9.10. Apullo RT Co., Ltd.
    • 9.11 Nemoto Kyorindo Co., Ltd.
  • Chapter No. 10 Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Product
FIG NO. 2. Market Attractiveness Analysis, By Application
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Contrast Injector Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Product, 2020 & 2028
FIG NO. 7. Global Contrast Injector Market for Injector Systems, Revenue (USD Million) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Contrast Injector Market for Injector Systems, By Country, 2020 & 2028
FIG NO. 9. Global Contrast Injector Market for Consumables, Revenue (USD Million) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Contrast Injector Market for Consumables, By Country, 2020 & 2028
FIG NO. 11. Global Contrast Injector Market for Accessories, Revenue (USD Million) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Contrast Injector Market for Accessories, By Country, 2020 & 2028
FIG NO. 13. Global Contrast Injector Market for others, Revenue (USD Million) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Contrast Injector Market for others, By Country, 2020 & 2028
FIG NO. 15. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 16. Global Contrast Injector Market for Radiology, Revenue (USD Million) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Contrast Injector Market for Radiology, By Country, 2020 & 2028
FIG NO. 18. Global Contrast Injector Market for Interventional Cardiology, Revenue (USD Million) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of Contrast Injector Market for Interventional Cardiology, By Country, 2020 & 2028
FIG NO. 20. Global Contrast Injector Market for Interventional Radiology, Revenue (USD Million) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Contrast Injector Market for Interventional Radiology, By Country, 2020 & 2028
FIG NO. 22. Global Contrast Injector Market Revenue Share, By Region, 2020 & 2028
FIG NO. 23. North America Contrast Injector Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 24. Porter’s Five Forces Analysis for Global Contrast Injector Market
FIG NO. 25. PEST Analysis for Global Contrast Injector Market
FIG NO. 26. Pricing Analysis for Global Contrast Injector Market
FIG NO. 27. Value Chain Analysis for Global Contrast Injector Market
FIG NO. 28. Company Share Analysis, 2019
FIG NO. 29. Radar Determinant Chart, 2019
FIG NO. 30. Company Strategic Developments – Heat Map Analysis
FIG NO. 31. Bayer HealthCare Business Segment Revenue Share, 2020 (%)
FIG NO. 32. Bayer HealthCare Geographical Segment Revenue Share, 2020 (%)
FIG NO. 33. Market Channels
FIG NO. 34. Marketing Channel Development Trend
FIG NO. 35. Growth in World Gross Product, 2008-2018
FIG NO. 36. Research Methodology – Detailed View
FIG NO. 37. Research Methodology


List of Tables 

TABLE NO. 1. Global Contrast Injector Market: Snapshot
TABLE NO. 2. Quarterly Contrast Injector Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Contrast Injector Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Contrast Injector Market for Injector Systems, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Contrast Injector Market for Consumables, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Contrast Injector Market for Accessories, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Contrast Injector Market for Radiology, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Contrast Injector Market for Interventional Cardiology, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Contrast Injector Market for Interventional Radiology, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Contrast Injector Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 13. North America Contrast Injector Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 14. North America Contrast Injector Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 15. North America Contrast Injector Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 16. U.S. Contrast Injector Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 17. U.S. Contrast Injector Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 18. Canada Contrast Injector Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 19. Canada Contrast Injector Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 20. Mexico Contrast Injector Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 21. Mexico Contrast Injector Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 22. Drivers for the Contrast Injector Market: Impact Analysis
TABLE NO. 23. Restraints for the Contrast Injector Market: Impact Analysis
TABLE NO. 24. Major Buyers of Contrast Injector
TABLE NO. 25. Distributors/Traders List of Contrast Injector
TABLE NO. 26. Global Contrast Injector Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 27. Global Contrast Injector Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)
 

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Contrast Injector market. Zion Research has collected and analyzed key data belong to the global Contrast Injector market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Contrast Injector across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Contrast Injector industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Contrast Injector market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Contrast injectors are medical devices used for injecting contrast media into the body to enhance the visibility of tissues for a medical imaging procedure. This contrast injector can be used as a part of imaging procedures that help in the diagnosis of vascular disease, heart disease, stroke, physical injury, cancer, digestive disorder and more. Nowadays, the implementation of contrast injector has increased all over the world as it provides better information and image data which is used in surgery planning and accurate diagnosis and prognosis of the disease.

A large number of approvals for contrast agents in different regions and increasing number of public and private diagnostic centers are factors driving the growth of contrast injector market. In addition increasing investment for research and development and rising awareness regarding the implementation of contrast agents in a medical procedure is fostering the growth of contrast injector market.  On the other hand side, effects and allergic reactions associated with contrast agents may hamper the growth of the market. However, untapped market, technological developments are expected to generate new opportunities during the forecast period.

Contrast injector market is categorized based on product category, application, and region. Based on product category contrast injector market is classified into injector systems, consumables, and accessories. The injector systems segment is further divided into CT, MRI and angiography injector systems. The CT injector systems segment dominated the market and accounted the largest share in 2016. The MRI injector systems segment is projected to grow at the highest CAGR during the forecast period.  The consumables segment is further divided into injector heads, tubing, syringes and other. The consumables segment is projected to account for the largest share of the market in 2016 owing to its extensive use in every procedure conducted. The injector heads segment is further bifurcated into a single head, dual head injectors, and syringe less injectors. The single head injectors are expected to account maximum share in 2016. On the basis of the application, the market is divided into radiology, interventional cardiology, and interventional radiology. Among this interventional cardiology dominated the market in 2016.

Key players operating in of contrast injector market are Bayer HealthCare, Guerbet Group, Aldrich GmbH & Co. KG, Medtron AG, GE Healthcare, S.P.A, AngioDynamics, Nemoto Kyorindo Co., Ltd., Sino Medical- Device Technology Co., Ltd., VIVID IMAGING , and  Apollo RT Co., Ltd.  

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global Contrast Injector market was valued at USD 765 Million in 2020.

The global contrast injector market is expected to reach USD 1,447 Million by 2028, growing at a CAGR of 8.2% from 2021 to 2028.

Growing healthcare industry around the world has accelerated the number of diagnosis done for detecting various disorders in humans. This rise in the number of tests has also been bolstered by increasing number of individuals suffering from cancer, brain disorders, spinal diseases, and physical injuries. Such growth in the number of  tests done is likely to boost the demand for contrast agents in medical diagnostic industry, which may also fuel the demand for contrast injectors.

North American region held a major share in the global contrast injectors market, constituting a market share of around 35% in 2020. Existing developed and established healthcare system in countries like United States and Canada has boosted adoption of advanced imaging technologies. Such adoption of advanced technologies should contribute to the growth of the contrast injector market growth.

Some of key players in contrast injector market are Bayer HealthCare, GE Healthcare, Bracco Imaging S.p.A., AngioDynamics, Medtron AG, ulrich GmbH & Co. KG, Guerbet Group, VIVID IMAGING , Sino Medical Device Technology Co., Ltd., Apollo RT Co., Ltd., and Nemoto Kyorindo Co., Ltd.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed